Future Innovations in Longevity Technology: Regenesome at LiSH FUTURE EXPO Regenesome Inc. will present groundbreaking findings in longevity technology at the LiSH FUTURE EXPO 2026, showcasing unique research collaborations and future visions.

Future Innovations in Longevity Technology: Regenesome at LiSH FUTURE EXPO #Longevity #Regenesome #LiSH_FUTURE_EXPO

Regenesome Takes Over Food Brand 'Gindou' to Implement Cutting-Edge Nano Research Regenesome has acquired the food brand 'Gindou' and launched its health-focused products. This new venture aligns with research in functional nanoparticles from Japanese cuisine.

Regenesome Takes Over Food Brand 'Gindou' to Implement Cutting-Edge Nano Research #Japan #Tokyo #Regenesome #SAKESOME #Gindou

Regenesome Partners with Shibaura Institute for Neural Cell Research Regenesome has entered into a collaborative research agreement with Shibaura Institute to study neural cell growth in microfluidic environments. The focus is on aging and space-related impacts on cells.

Regenesome Partners with Shibaura Institute for Neural Cell Research #Japan #Tokyo #Microfluidics #Shibaura_Institute #Regenesome

Regenesome Receives Venture Certification from Tokyo Institute of Science, Leading Innovation in Longevity Science Regenesome has been certified as a venture by the Tokyo Institute of Science, marking a significant milestone in its commitment to advancing longevity science through innovation and collaboration.

Regenesome Receives Venture Certification from Tokyo Institute of Science, Leading Innovation in Longevity Science #Japan #Tokyo #Regenesome #Tokyo_Institute #Space_Seed

Regenesome Selected as Finalist in Japan BeautyTech Awards 2025 Regenesome has been selected as a finalist in the 6th Japan BeautyTech Awards 2025 for its innovative epigenetic clock technology using DNA methylation.

Regenesome Selected as Finalist in Japan BeautyTech Awards 2025 #Japan #Tokyo #Regenesome #BeautyTech #Epigenetic_Clock

Regenesome Secures Funding Through J-KISS for Aging Research and Space Medicine Regenesome, a subsidiary of Space Seed Holdings, raises 20 million yen through J-KISS funding aimed at developing aging prevention technologies for lunar habitation.

Regenesome Secures Funding Through J-KISS for Aging Research and Space Medicine #Japan #Tokyo #Longevity #Regenesome #Space_Seed

Celebrating One Year of Regenesome: Achievements and Future Directions in Longevity Research Regenesome marks its first anniversary with an event highlighting research achievements and future projects aimed at tackling aging challenges in healthcare.

Celebrating One Year of Regenesome: Achievements and Future Directions in Longevity Research #Longevity #Exosomes #Regenesome

Space Seed Holdings Showcases Innovations at Global Knowledge Hub Forum 2025 in Singapore Space Seed Holdings showcased its groundbreaking research at the Global Knowledge Hub Forum 2025 in Singapore. Themes included longevity and space innovations.

Space Seed Holdings Showcases Innovations at Global Knowledge Hub Forum 2025 in Singapore #Japan #Tokyo #Space_Seed_Holdings #Regenesome #Global_Knowledge_Hub

Regenesome Files Patent for Advanced Epigenetic Clock Using Biological Samples Regenesome, a subsidiary of Space Seed Holdings, has developed an advanced algorithm predicting biological age using biological samples, filing for a patent.

Regenesome Files Patent for Advanced Epigenetic Clock Using Biological Samples #Japan #Tokyo #Space_Seed_Holdings #Regenesome #Epigenetic_Clock

Sharing Progress on Aging Care Research: Regenesome's 1st Anniversary Celebration Join Regenesome for its 1st anniversary event featuring research progress on aging care and insights into future endeavors. Free to attend!

Sharing Progress on Aging Care Research: Regenesome's 1st Anniversary Celebration #Japan #healthcare #Tokyo #Anti-Aging #Regenesome

Kengo Suzuki from Space Seed Holdings Presents at IVS2025 on Social Implementation of Technology Kengo Suzuki of Space Seed Holdings discussed technology implementation at IVS2025, showcasing innovative solutions for future space living.

Kengo Suzuki from Space Seed Holdings Presents at IVS2025 on Social Implementation of Technology #Japan #Kyoto #Regenesome #Space_Seed #IVS2025

Exploring Longevity Research Through Data Science at Tokyo Science University The Longevity Research seminar at Tokyo Science University highlighted innovative approaches using data science to tackle modern health challenges.

Exploring Longevity Research Through Data Science at Tokyo Science University #Japan #Tokyo #Regenesome #Tokyo_Science_University #Longevity_Research

Regenesome Inc. Launches New Longevity Lab at Takanawa Gateway City Regenesome Inc. announces the opening of its new research facility in Takanawa Gateway City, focusing on aging biotechnology and innovative healthcare solutions.

Regenesome Inc. Launches New Longevity Lab at Takanawa Gateway City #Japan #Tokyo #LiSH #Regenesome #Takanawa